{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T13:22:04Z","timestamp":1769433724897,"version":"3.49.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:p><jats:italic>Background and Purpose<\/jats:italic>\u2014Parenterally administered MgSO<jats:sub>4<\/jats:sub>is neuroprotective in standard animal models of focal cerebral ischemia and in many other paradigms of brain injury. Previous small clinical trials in stroke patients have explored the safety and tolerability of different infusion regimens. This study was undertaken to optimize the regimen for a multicenter trial.<\/jats:p><jats:p><jats:italic>Methods<\/jats:italic>\u2014 Within 24 hours of the onset of clinically diagnosed stroke, patients were randomized to receive placebo or one of three intravenous MgSO<jats:sub>4<\/jats:sub>infusions: a loading infusion of 8, 12, or 16 mmol, followed by 65 mmol over 24 hours. Cardiovascular parameters, serum magnesium concentrations, and blood glucose concentrations were determined. Outcome at 30 and 90 days was recorded.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>\u2014Twenty-five patients were recruited and treated at a mean time of 20 hours after stroke. No tolerability problems were identified. No effects of magnesium on heart rate, blood pressure, or blood glucose were evident. Serum magnesium concentrations rose to target levels most rapidly in the highest loading infusion group and were maintained in all groups for at least 24 hours.<\/jats:p><jats:p><jats:italic>Conclusions<\/jats:italic>\u2014MgSO<jats:sub>4<\/jats:sub>infusions that rapidly elevate the serum magnesium concentration to potentially therapeutic levels are well tolerated and have no major hemodynamic effects in patients with acute stroke. The 16-mmol loading infusion achieved target serum concentrations most rapidly and has been chosen for further trials.<\/jats:p>","DOI":"10.1161\/01.str.29.5.918","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:08:03Z","timestamp":1308341283000},"page":"918-923","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":78,"title":["Dose Optimization of Intravenous Magnesium Sulfate After Acute Stroke"],"prefix":"10.1161","volume":"29","author":[{"given":"Keith W.","family":"Muir","sequence":"first","affiliation":[{"name":"From the Acute Stroke Unit, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennedy R.","family":"Lees","sequence":"additional","affiliation":[{"name":"From the Acute Stroke Unit, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1996.85.1.0117"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90471-K"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90569-U"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1991.170"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91188-8"},{"key":"e_1_3_2_6_2","first-page":"196","volume":"304","year":"1990","unstructured":"Chi OZ, Pollak P, Weiss HR. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther. 1990;304:196\u2013205.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90572-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90153-7"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90284-0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1985.tb12922.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1980.sp013443"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/307462a0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1988.sp017078"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/358673a0"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb11975.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(88)90087-1"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1995.tb00273.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198811000-00012"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(93)90023-2"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(85)80789-4"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.26.7.1183"},{"key":"e_1_3_2_22_2","first-page":"143","volume":"70","year":"1984","unstructured":"Wester PO, Asplund K, Eriksson S, Hagg E, Lithner F, Strand T. Infusion of magnesium in patients with acute brain infarction. Acta Neurol Scand. 1984;70:143. Abstract.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93206-O"},{"key":"e_1_3_2_24_2","first-page":"61","volume":"14","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md Med J. 1965;14:61\u201365.","journal-title":"Md Med J"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/003693305700200504"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.19.5.3363593"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90058-V"},{"key":"e_1_3_2_28_2","first-page":"S103","volume":"17","year":"1997","unstructured":"Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen H. Additive neuroprotective effects of magnesium and tirilazad in rats subjected to transient focal cerebral ischemia. J Cereb Blood Flow Metab. 1997;17:S103. Abstract.","journal-title":"J Cereb Blood Flow Metab"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100041202"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.15.4.6464063"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0850175"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90289-G"},{"key":"e_1_3_2_33_2","first-page":"R158","volume":"266","year":"1994","unstructured":"Huang QF, Gebrewold A, Zhang A, Altura BT, Altura BM. Role of excitatory amino acids in regulation of rat pial microvasculature. Am J Physiol. 1994;266:R158\u2013R163.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.22.7.1853412"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(92)91749-Z"},{"key":"e_1_3_2_36_2","first-page":"181","volume":"20","year":"1994","unstructured":"Sjostrom LG, Wester P. Systemically induced hypermagnesemia increases the bioavailability of magnesium in rat brain. Soc Neurosci. 1994;20:181. Abstract.","journal-title":"Soc Neurosci"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91034-4"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330401"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(87)80239-9"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349309058156"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(92)91737-U"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91828-V"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92024-9"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90865-X"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.20.4.2648653"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1159\/000108087"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(25)22222-4","volume":"246","year":"1988","unstructured":"Nishio A, Gebrewold A, Altura BT, Altura BM. Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictor agents: an in situ study on microcirculation. J Pharmacol Exp Ther. 1988;246:859\u2013865.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.29.5.918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T08:31:40Z","timestamp":1741249900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.29.5.918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1161\/01.STR.29.5.918"],"URL":"https:\/\/doi.org\/10.1161\/01.str.29.5.918","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]},"assertion":[{"value":"1997-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}